autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T cells

{
  "id": "MLC-T-ONC-011645",
  "term": "autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T cells",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of CD4+ and CD8+ autologous T lymphocytes transduced with a lentiviral vector expressing a human epidermal growth factor receptor type 2 (HER2; EGFR2; ErbB2)-specific chimeric antigen receptor (CAR) coupled to a truncated form of the human epidermal growth factor receptor (EGFRt), with potential immunostimulating and antineoplastic activities. Upon intravenous administration, the autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T cells are directed to and induce selective toxicity in HER2-expressing tumor cells. Devoid of both ligand binding domains and tyrosine kinase activity, the expressed EGFRt both facilitates in vivo detection of the administered, transduced T cells and can promote elimination of these cells through an anti-EGFR antibody-induced antibody-dependent cellular cytotoxicity (ADCC) response. HER2, a receptor tyrosine kinase (RTK) overexpressed by a variety of tumor cell types, belongs to the EGFR superfamily and plays a key role in tumor cell proliferation.",
  "synonyms": [
    "autologous HER2 CAR/EGFRt-expressing CD4+ and CD8+ T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-her2-specific-egfrt-expressing-cd4-cd8-positive-car-t-cells/"
}